Founded in 1994, Exelixis, Inc. (NASDAQ: EXEL) is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines for difficult-to-treat cancers. Following early work in model genetic systems, we established a broad drug discovery and development platform that has served as the foundation for our continued efforts to bring new cancer therapies to patients in need. We discovered our lead compounds, cabozantinib and cobimetinib, and advanced them into clinical development before entering into partnerships with leading biopharmaceutical companies in our efforts to bring these medicines to patients globally. We are steadfast in our commitment to prudently reinvest in our business to maximize the potential of our pipeline. We intend to supplement our existing therapeutic assets with targeted business development activities and internal drug discovery – all to deliver the next generation of Exelixis medicines and help patients recover stronger and live longer. Exelixis recently earned a spot on Deloitte’s Technology Fast 500 list, a yearly award program honoring the 500 fastest-growing companies over the past four years.
The Exelixis Credo
We drive for results, so patients can survive and thrive.
We are resilient in the face of adversity, and tireless in advancing our science.
We celebrate our long history of prolific drug discovery and rigorous drug development.
We unite to launch innovative medicines for difficult-to-treat cancers.
We exist to give people hope – one drug, one patient at a time.
We are Exelixis.
There’s a lot at stake in the work we do. Patients living with cancer count on our medicines to give them more time with the people they love.
We come to work every day driven by an unwavering belief in each other and our science. As teams, we strive to deliver results and exceed expectations in taking drug discovery, development and commercialization to a bold level of excellence to treat and defeat cancer. Our focus and commitment is clear: to discover, develop and bring to market new medicines that give patients and their families hope for the future.
We are Driven by an Ambitious Cause
At Exelixis, our focus and commitment is clear: to launch new medicines that give patients and their families hope for the future. This calling unites and inspires us every day to accomplish all we can for patients living with cancer.
Exelixis’ Cultural DNA
Our people share a rare blend of intelligence, professionalism, humility and compassion. Everyone brings their “A” game. We genuinely care about our colleagues and help each other succeed. Over the past two decades, our resilience has been tested and proven. We have not just survived. We have thrived. We continue to approach our work with integrity, rigor, resourcefulness and speed because patients count on our medicines to give them more time with the people they love.
Be Exceptional. Excel for Patients. Exceed Together.
This is the call to action that drives our values, simply stated. We are empowered to make decisions, bring our best thinking and leverage our experience to move as fast as we can. When CABOMETYX® was approved, we had it in the hands of our first patient in just three days. Planning and speed matters when it comes to giving more time to patients.
Join our Quest to Treat and Defeat Cancer
At Exelixis, everyone is focused on one common goal – launching new medicines that give patients and their families hope for the future. Our employees are our most valuable asset, and are essential to helping us realize our maximum potential.
Do you share our passion for improving the lives of people living with cancer? Please use the system below to browse available job openings.
Notice to Recruiters/Staffing Agencies:
Recruiters and staffing agencies should not contact Exelixis, Inc. through this page. We require that all recruiters and staffing agencies have a signed contract on file and be assigned a specific search by our human resources department. Any resumes submitted through the website or directly by recruiters or staffing agencies that do not meet the above-mentioned criteria will be considered unsolicited and the company will not be responsible for any related fees.
Management is terrific and the work meaningful and impactful for patients with cancer.
Really not any cons I can think of.
I applied through a staffing agency. The process took 1 day. I interviewed at Exelixis.
Great, panel interview but everyone was awesome. Meet with 4 people something I have never done before, but it was worth while to hear everyone's experience and feedback within the company.
Let us know if we're missing any workplace or industry recognition –